Pooled analysis of large and long‐term safety data from the human papillomavirus‐16/18‐AS04‐adjuvanted vaccine clinical trial programme
Author:
Affiliation:
1. GlaxoSmithKline Vaccines Wavre Belgium
2. GlaxoSmithKline Vaccines King of Prussia PA USA
Publisher
Wiley
Subject
Pharmacology (medical),Epidemiology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.3554
Reference44 articles.
1. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
2. The safety evaluation of adjuvants during vaccine development: The AS04 experience
3. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
4. Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
5. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Does HPV vaccination during periconceptional or gestational period increase the risk of adverse pregnancy outcomes?—An updated systematic review and meta‐analysis based on timing of vaccination;Acta Obstetricia et Gynecologica Scandinavica;2024-08-06
2. Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review;Vaccine: X;2024-06
3. Vaccination and the risk of systemic lupus erythematosus: a meta-analysis of observational studies;Arthritis Research & Therapy;2024-03-04
4. Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis;Vaccine;2023-06
5. Association of periconceptional or pregnancy exposure of HPV vaccination and adverse pregnancy outcomes: a systematic review and meta-analysis with trial sequential analysis;Frontiers in Pharmacology;2023-05-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3